Evidence map›Paper›PMID 29355173›Full record

ReviewNature reviews. Nephrology2018

Paradigms of acute kidney injury in the intensive care setting.

John A Kellum, John R Prowle

3 registry-linked trialsAbstract readReview
PubMed Publisher
In one paragraph

Review in Nature reviews. Nephrology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 204 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
204citing papers in PubMed, 4 pooled it
27.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04530448 phase4terminatednot on this mapstarted 2020, after this paper: background citation

Coronavirus Induced Acute Kidney Injury: Prevention Using Urine Alkalinization

TypeinterventionalSponsorWest Virginia UniversityRan2020 to 2021Enrolled3ConditionsCOVID, Coronavirus, Coronavirus Infection, AKIArmsSodium bicarbonate, Standard of Care
NCT05542927 unknown statusnot on this mapstarted 2022, after this paper: background citation

Incidence of Acute Kidney Injury and Mortality in Critically Ill Patients: Urinary Chloride as a Prognostic Marker

Typeobservational_patient_registrySponsorAin Shams UniversityRan2022 to 2023Enrolled90ConditionsAcute Kidney InjuryArmsurine chloride
NCT05559086 unknown statusnot on this mapstarted 2022, after this paper: background citation

Neutrophils to Lymphocytes and Platelets Ratio (N/LP) as Predictor of Mortality in Septic- Acute Kidney Injury Patients

TypeobservationalSponsorMahmoud Kamel Mohamed Abd elhaqRan2022 to 2025Enrolled200ConditionsAcute Kidney Injury Due to Sepsis
3 · Its place in the literature

Who cites it

204 citing papers in PubMed, 4 syntheses or guidelines pooled it, 401 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Guideline
  5. Trial
  6. Trial
  7. Article
  8. Article
  9. Electronic Phenotype for Detection, Staging, and Subtyping of Acute Kidney Injury.American journal of kidney diseases : the official journal of the National Kidney Foundation · 2026
    Article
  10. Article
  11. Article
  12. Article
  13. Caveolin-1 Stabilizes SERCA2 to Counteract Acute Kidney Injury via Suppression of CaAdvanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  14. Preventing pediatric acute kidney injury: is it even possible?Pediatric nephrology (Berlin, Germany) · 2026
    Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. The m5C orchestrator NSUN7 drives SPARC/HMGB1 axis-mediated inflammation to exacerbate kidney injury.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  20. Article

144 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

John A KellumCenter for Critical Care Nephrology, Department of Critical Care Medicine, University of Pittsburgh School of Medicine and University of Pittsburgh Medical Center, 3347 Forbes Avenue, Suite 220, Pittsburgh, Pennsylvania 15213, USA.
John R ProwleAdult Critical Care Unit, Department of Renal and Transplant Medicine, The Royal London Hospital, Whitechapel Road, London E1 1BB, UK.
University of Pittsburgh Medical Center · USWilliam Harvey Research Institute · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Acute kidney injury (AKI) is a heterogeneous clinical syndrome that has multiple aetiologies, variable pathogenesis and diverse outcomes. However, these heterogeneities are not reflected in current approaches to the diagnosis and, to some degree, treatment of AKI. For example, congestive heart failure and dehydration can produce identical changes in serum creatinine level and urine output (parameters that are used to define AKI); however, they differ vastly in their physiological contexts and demand completely opposite treatments. AKI is often still considered to be a homogeneous clinical entity, which implies a uniform pathogenesis and a well-defined prognosis. As a consequence, efforts to find effective AKI treatments have been hampered by a lack of clear clinical classifications for various types of AKI. In addition, subclassification of AKI into subclinical phenotypes - for example, on the basis of protein biomarkers and other in vitro diagnostics that take into account disease aetiology and underlying pathogenesis - might be necessary to develop therapeutic approaches that effectively target the widely differing pathomechanisms of AKI. In this Review, we discuss the major subtypes of AKI that are associated with sepsis, major surgery, renal hypoperfusion and nephrotoxin exposure -situations that are typically seen in the intensive care setting. We consider differences and similarities in their phenotype, pathogenesis and outcomes and how this information might be used to guide treatment.

Indexed as

Acute Kidney InjuryIntensive Care UnitsBiomarkersHumansPhenotypePrognosisBiomarkers

Identifiers

PMID29355173
OpenAlexW2785291160

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.